Clinical Trial of HY004 Cell Injection in the Treatment of Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Non-Hodgkin Lymphoma
Related studies linked through entity extraction aliases.
Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors
- Status
- RECRUITING
- Phase
- N/A
Ibrutinib Combination Therapy in Transplant Ineligible Individuals With Newly Diagnosed Primary CNS Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Phase 1, Open-label, Dose-escalation Trial With CD38-SADA:177 Lu-DOTA Drug Complex in Subjects With Relapsed or Refractory Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients
- Status
- AVAILABLE
- Phase
- N/A
Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study
- Status
- COMPLETED
- Phase
- NA
A Study to Assess Safety and Efficacy of CHO-H01 as a Single Agent/Combined With Lenalidomide in Subjects With Refractory or Relapsed Non-Hodgkin's Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Biochemical Role of Circulating microRNAs Expression as Diagnostic Markers for Non-Hodgkin's Lymphoma Patients
- Status
- RECRUITING
- Phase
- N/A
A Study to Learn About the Study Medicine (Maplirpacept) in People With Advanced Non-Hodgkin Lymphoma or Multiple Myeloma in China
- Status
- COMPLETED
- Phase
- PHASE1
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Evaluate Safety of Axicabtagene Ciloleucel Reinfusion (Axi-Cel-2) in Patients With Relapsed and/or Refractory Second Line High-Risk Non-Hodgkin Lymphoma After Standard of Care Axi-Cel
- Status
- RECRUITING
- Phase
- PHASE1
A Rollover Study of CC-122
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
WTX-330 in Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Siltuximab for the Prevention of CAR T Cell Related Cytokine Release Syndrome in Patients With CD19 Positive Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
NKTR-255 vs Placebo Following CD19-directed CAR-T Therapy in Patients With Relapsed/Refractory Large B-cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE3
A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of GNC-038 Injection in Patients With Relapsed or Refractory NK/ T-cell Lymphoma, AITL, and Other NHL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
First in Human, Dose Escalation, Dose Expansion Study of AUR105
- Status
- TERMINATED
- Phase
- PHASE1
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1